Diffuse neonatal hemangiomatosis: Report of 5 cases

Journal of the Medical Association of Thailand

Volumn 89, Issue 8, 2006, Pages 1297-1303

  Wananukul, Siriwan ^a   Voramethkul, Wanlapa ^a   Nuchprayoon, Issarang ^a   Seksarn, Panya ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Diffuse neonatal hemangiomatosis; Interferon; Prednisolone; Vinblastine

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIGOXIN; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INOTROPIC AGENT; INTERFERON; PREDNISOLONE; SPIRONOLACTONE; VINBLASTINE;

ANAMNESIS; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMANGIOMATOSIS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INFANT; LIVER DISEASE; LONG TERM CARE; MALE; NEUROLOGIC EXAMINATION; NEWBORN DISEASE; PHYSICAL EXAMINATION; RADIODIAGNOSIS; SKIN BIOPSY; SKIN HEMANGIOMA;

ANGIOMATOSIS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; PREDNISOLONE; SKIN NEOPLASMS; VINBLASTINE;

EID: 33748517853     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ronan SG, Solomon LM. Benign neonatal eruptive hemangiomatosis in identical twins. Pediatr Dermatol 1984; 1: 318-21.
2. Stern JK, Wolf JE Jr, Jarratt M. Benign neonatal hemangiomatosis. J Am Acad Dermatol 1981; 4: 442-5.
3. Stenninger E, Schollin J. Diffuse neonatal haemangiomatosis in a newborn child. Acta Paediatr 1993; 82: 102-4.
4. Geller JD, Topper SF, Hashimoto K. Diffuse neonatal hemangiomatosis: a new constellation of findings. J Am Acad Dermatol 1991; 24: 816-8.
5. Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993; 10: 311-3.
6. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL. Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med 1989; 320: 1197-200.
7. Ezekowitz RA, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326: 1456-63.
8. O'Hagan AH, Irvine AD, Sands A, O'Donaghue D, Casey F, Bingham EA. Miliary neonatal hemangiomatosis with fulminant heart failure and cardiac septal hypertrophy in two infants. Pediatr Dermatol 2004; 21: 469-72.
9. Golitz LE, Rudikoff J, O'Meara OP. Diffuse neonatal hemangiomatosis. Pediatr Dermatol 1986; 3: 145-52.
10. Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr 1999; 88: 93-7.
11. Vorse HB, Smith EI, Luckstead EF, Fraser JJ Jr. Hepatic hemangiomatosis of infancy. Am J Dis Child 1983; 137: 672-3.
12. Keller L, Bluhm JF III. Diffuse neonatal hemangiomatosis. A case with heart failure and thrombocytopenia. Cutis 1979; 23: 295-7.
13. Kassarjian A, Dubois J, Burrows PE. Angiographic classification of hepatic hemangiomas in infants. Radiology 2002; 222: 693-8.
14. Stratte EG, Tope WD, Johnson CL, Swanson NA. Multimodal management of diffuse neonatal hemangiomatosis. J Am Acad Dermatol 1996; 34: 337-42.
15. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, Mac DD, Folkman J, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998; 132: 527-30.
16. Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, Ria R, et al. Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 1999; 94: 4143-55.
17. Moore J, Lee M, Garzon M, Soffer S, Kim E, Saouaf R, et al. Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg 2001; 36: 1273-6.
18. Wananukul S, Nuchprayoon I, Seksarn P. Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol 2003; 42: 741-8.
19. Perez PJ, Pardo MJ, Gomez BC. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995; 333: 69.